Compounds > propiolactone

propiolactone and HIV

propiolactone has been researched along with HIV in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (83.33)	18.7374
1990's	1 (16.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barford, JP; Harbour, C; MacLeod, AJ; Spencer, J; Woodhouse, G	1
Stephan, W	1
Deinhardt, F; Dichtelmüller, H; Gürtler, L; Prince, AM; Stephan, W	1
Giorgi, JV; Nishanian, PG; Ojo-Amaize, E; Uittenbogaart, CH	1
Ball, MJ; Chapel, H; Spriggs, V; Sutton, PM	1
Brackmann, HH; Heinrich, D; Lissner, R; Stephan, W; Sugg, U	1

Reviews

1 review(s) available for propiolactone and HIV

Article	Year
Inactivation of hepatitis viruses and HIV in plasma and plasma derivatives by treatment with beta-propiolactone/UV irradiation. Current studies in hematology and blood transfusion, 1989, Issue:56 Topics: Animals; Blood Component Removal; Chemical Fractionation; Hepatitis Viruses; HIV; Humans; Lactones; Plasma; Propiolactone; Sterilization; Ultraviolet Rays	1989

Other Studies

5 other study(ies) available for propiolactone and HIV

Article	Year
Viral contamination of therapeutic proteins: a challenge for downstream processing. Australian journal of biotechnology, 1991, Volume: 5, Issue:2 Topics: Antibodies, Monoclonal; Blood Proteins; Deltaretrovirus; Drug Contamination; Freeze Drying; HIV; Hot Temperature; Humans; Organophosphates; Propiolactone; Proteins; Virus Diseases; Viruses	1991
Inactivation of HIV in plasma derivatives by beta-propiolactone and UV irradiation. Infection, 1987, Volume: 15, Issue:5 Topics: Drug Contamination; Factor VIII; Fibrinogen; Fibronectins; HIV; Humans; Plasma; Propiolactone; Ultraviolet Rays	1987
A simple and rapid method for preparation of HIV-expressing targets for functional assays. Journal of immunological methods, 1988, Mar-16, Volume: 107, Issue:2 Topics: Antibodies, Viral; Antibody-Dependent Cell Cytotoxicity; Antigens, Viral; Cell Line; Culture Techniques; Flow Cytometry; HIV; HIV Antibodies; Humans; Lymphocytes; Propiolactone; Receptors, Virus	1988
Effect of beta-propiolactone--an inhibitor of HTLV III/LAV activity--on immunological analyses. Journal of immunological methods, 1986, Dec-04, Volume: 95, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Antibodies, Viral; HIV; Immunoassay; Lactones; Lymphocytes; Propiolactone	1986
Virus safety of beta-propiolactone treated plasma preparations. Clinical experiences. Developments in biological standardization, 1987, Volume: 67 Topics: Acquired Immunodeficiency Syndrome; Factor IX; Hemophilia A; Hepatitis Viruses; Hepatitis, Viral, Human; HIV; Humans; Lactones; Propiolactone; Sterilization; Ultraviolet Rays	1987